KfB
reacted to
In the coming weeks, major companies will be competing to release their earnings reports.
Including notable appearances from companies like $Alphabet-A (GOOGL.US)$ $Microsoft (MSFT.US)$ $Meta Platforms (META.US)$ $Apple (AAPL.US)$ and $Amazon (AMZN.US)$ .
Earnings season often brings heightened market volatility, presenting a mix of challenges and opportunities for investors.
For options traders, ...
Including notable appearances from companies like $Alphabet-A (GOOGL.US)$ $Microsoft (MSFT.US)$ $Meta Platforms (META.US)$ $Apple (AAPL.US)$ and $Amazon (AMZN.US)$ .
Earnings season often brings heightened market volatility, presenting a mix of challenges and opportunities for investors.
For options traders, ...
+1
101
9
KfB
liked
Investing in dividend stocks emphasizes the three words "slow, steady, and patient." These three words may seem simple but few people can actually achieve them because compared to the excitement of making quick profits, this investment approach is really too boring.
Reviewing the performance of dividend stocks at the end of 2022 (article dated 3 Jan 2023), the average return of the top 30 dividend stocks was 7.19%, with a ratio of 20:10 for increases versus decreases. In the same year, the USA's S&P500 dropped by 19.44%, and Malaysia's FBMSCAP dropped by 5.30%. Many readers commented that it was simply luck as the dividend stocks happened to be bouyed up at the end of the year.
Looking at the performance of dividend stocks at the end of 2023 (article dated 31 Dec 2023), the average return of the top 30 dividend stocks was 13.82%, with a ratio of 23:7 for increases versus decreases. In the same year, the USA's S&P500 rose by 24.23%, and Malaysia's FBMSCAP rose by 9.57%. Still, many readers felt that it was simply luck.
As of October 13, 2024, the average return of the top 30 dividend stocks from the beginning of the year until now is 24.20%, with a ratio of 28:2 for increases versus decreases. Among these:
18 of them have increased by 20% or more
The increase in the six companies reached 10% or more.
Only 2 companies experienced a decrease of 5% or more.
In 2024, the performance of dividend-paying stocks can only be said to be unexpectedly good, mainly because these dividends are generous, and companies with a solid foundation have become a safe haven for funds in the market downturn.
The market's downturn in the second half of 2024 mainly occurred...
Reviewing the performance of dividend stocks at the end of 2022 (article dated 3 Jan 2023), the average return of the top 30 dividend stocks was 7.19%, with a ratio of 20:10 for increases versus decreases. In the same year, the USA's S&P500 dropped by 19.44%, and Malaysia's FBMSCAP dropped by 5.30%. Many readers commented that it was simply luck as the dividend stocks happened to be bouyed up at the end of the year.
Looking at the performance of dividend stocks at the end of 2023 (article dated 31 Dec 2023), the average return of the top 30 dividend stocks was 13.82%, with a ratio of 23:7 for increases versus decreases. In the same year, the USA's S&P500 rose by 24.23%, and Malaysia's FBMSCAP rose by 9.57%. Still, many readers felt that it was simply luck.
As of October 13, 2024, the average return of the top 30 dividend stocks from the beginning of the year until now is 24.20%, with a ratio of 28:2 for increases versus decreases. Among these:
18 of them have increased by 20% or more
The increase in the six companies reached 10% or more.
Only 2 companies experienced a decrease of 5% or more.
In 2024, the performance of dividend-paying stocks can only be said to be unexpectedly good, mainly because these dividends are generous, and companies with a solid foundation have become a safe haven for funds in the market downturn.
The market's downturn in the second half of 2024 mainly occurred...
Translated
75
1
KfB
commented on
$UCHITEC (7100.MY)$ If this trend stays, it will reach green upward trend in another couple of sessions. Should i buy now then? A bit hesitant since i dont have much, but if i am a gambler i would buy now.
P.S. I am a really really bad gambler...haha
P.S. I am a really really bad gambler...haha
1
2
KfB
reacted to
13
KfB
liked
The outlook for future glove demand may exceed expectations, according to Kenanga Investment Bank. $TOPGLOV (7113.MY)$
The future performance is more optimistic, with a significant increase of 39% and 42% in net profit forecasts for the fiscal years 2025 and 2026 (ending at the end of August).
Following recent meetings with senior management of top glove, analysts at Kenanga Investment Bank are optimistic about the company's performance outlook.
"There are signs that top glove will experience a stronger demand rebound than expected after entering the 2025 fiscal year."
He added that top glove's sales continued to rise month by month in September this year, with the company also expecting customers' inventory replenishment activities to strengthen in the coming quarters.
"Currently, top glove's sales volume is increasing by 25% to 30% per month, aiming to improve overall capacity utilization to 65% to 70%. We originally predicted that the company's capacity utilization for the fiscal year 2025 would only be 55%."
In addition, the analyst pointed out that top glove's export volume to the USA continues to improve, now accounting for 28% to 30% of its global sales.
"Top glove believes this is due to stocking activities by US customers, coupled with more Chinese glove manufacturers being listed by the country's Food and Drug Administration (FDA) as a watchlist, while the capacity utilization of Chinese peers has also reached 90%, almost at full production capacity."
Analysts believe that top glove is optimistic about the price trend of average glove prices, predicting that the average price will gradually increase in the future, with a possible increase of 5% to 15%...
The future performance is more optimistic, with a significant increase of 39% and 42% in net profit forecasts for the fiscal years 2025 and 2026 (ending at the end of August).
Following recent meetings with senior management of top glove, analysts at Kenanga Investment Bank are optimistic about the company's performance outlook.
"There are signs that top glove will experience a stronger demand rebound than expected after entering the 2025 fiscal year."
He added that top glove's sales continued to rise month by month in September this year, with the company also expecting customers' inventory replenishment activities to strengthen in the coming quarters.
"Currently, top glove's sales volume is increasing by 25% to 30% per month, aiming to improve overall capacity utilization to 65% to 70%. We originally predicted that the company's capacity utilization for the fiscal year 2025 would only be 55%."
In addition, the analyst pointed out that top glove's export volume to the USA continues to improve, now accounting for 28% to 30% of its global sales.
"Top glove believes this is due to stocking activities by US customers, coupled with more Chinese glove manufacturers being listed by the country's Food and Drug Administration (FDA) as a watchlist, while the capacity utilization of Chinese peers has also reached 90%, almost at full production capacity."
Analysts believe that top glove is optimistic about the price trend of average glove prices, predicting that the average price will gradually increase in the future, with a possible increase of 5% to 15%...
Translated
19
3
KfB
voted
Hi mooers!
$NVIDIA (NVDA.US)$ is releasing its Q2 earnings on August 28 after the bell. Unlock insights with NVDA Earnings Hub>>
For the details of indicator sentiment, please tap the link and check.
Since its last earnings release, shares of $NVIDIA (NVDA.US)$ have seen an increase of 35.64%. What do you think of this earnings report? Let's see if you can be motivated by the following information!
Mooer's insights:
· @Mr Long Te...
$NVIDIA (NVDA.US)$ is releasing its Q2 earnings on August 28 after the bell. Unlock insights with NVDA Earnings Hub>>
For the details of indicator sentiment, please tap the link and check.
Since its last earnings release, shares of $NVIDIA (NVDA.US)$ have seen an increase of 35.64%. What do you think of this earnings report? Let's see if you can be motivated by the following information!
Mooer's insights:
· @Mr Long Te...
+8
101
116
KfB
liked
Due to the intensified competition in the industry caused by the expansion of Chinese production capacity, the research department of a Malaysian bank lowered the ratings of local glove stocks from "positive" to "tactical positive," leading to a decline in the stock prices of local glove companies.
After a full decline on Monday (29th), the three local glove companies continued to bleed and their decline expanded further during the midday break on Tuesday (30th). Among the four big players, the decline exceeded 4%. $KOSSAN (7153.MY)$ 、 $HARTA (5168.MY)$ and $TOPGLOV (7113.MY)$ The decline exceeded 4% for all four big players.
$HARTA (5168.MY)$
$TOPGLOV (7113.MY)$
$SUPERMX (7106.MY)$
$KOSSAN (7153.MY)$
Modernization of Chinese Enterprises
Maybank Investment Banking released an analysis report, stating that the visits to Shandong Province by Intco Medical and Blue Sail Medical last week left a deep impression on analysts about the advanced technology of Chinese enterprises!
Analysts observed that Intco's factory has modern facilities for production lines, packaging, and warehousing; Blue Sail's factory, however, is similar to local glove companies, with the exception of packaging and warehousing methods.
The utilization rate of factory facilities for the two glove companies in China is nearly 100%, and both are looking to expand production capacity and target the Southeast Asian market, including China.
In addition to expanding into overseas markets and increasing production capacity, Intco is also interested in developing non-glove products.
After a full decline on Monday (29th), the three local glove companies continued to bleed and their decline expanded further during the midday break on Tuesday (30th). Among the four big players, the decline exceeded 4%. $KOSSAN (7153.MY)$ 、 $HARTA (5168.MY)$ and $TOPGLOV (7113.MY)$ The decline exceeded 4% for all four big players.
$HARTA (5168.MY)$
$TOPGLOV (7113.MY)$
$SUPERMX (7106.MY)$
$KOSSAN (7153.MY)$
Modernization of Chinese Enterprises
Maybank Investment Banking released an analysis report, stating that the visits to Shandong Province by Intco Medical and Blue Sail Medical last week left a deep impression on analysts about the advanced technology of Chinese enterprises!
Analysts observed that Intco's factory has modern facilities for production lines, packaging, and warehousing; Blue Sail's factory, however, is similar to local glove companies, with the exception of packaging and warehousing methods.
The utilization rate of factory facilities for the two glove companies in China is nearly 100%, and both are looking to expand production capacity and target the Southeast Asian market, including China.
In addition to expanding into overseas markets and increasing production capacity, Intco is also interested in developing non-glove products.
Translated
34
KfB
voted
Hi, mooers!
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Apple's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Apple and earn plenty of rewards! Don't miss the chance to win big>>
$Apple (AAPL.US)$ is releasing its Q3 FY2024 earnings on August 1 after the bell. Unlock insights with Apple Earnings Hub>>
For the details of i...
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Apple's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Apple and earn plenty of rewards! Don't miss the chance to win big>>
$Apple (AAPL.US)$ is releasing its Q3 FY2024 earnings on August 1 after the bell. Unlock insights with Apple Earnings Hub>>
For the details of i...
103
191